drug development

Do big R&D budgets justify US premium drug prices? No way, analysts scoff
Do big R&D budgets justify US premium drug prices? No way, analysts scoff
Endpoints
drug development
R&D
drug pricing
Flag link:
Doctors Alarmed by Post-antibiotic Future
Doctors Alarmed by Post-antibiotic Future
VOA News
antibiotics
antibiotic resistance
R&D
drug development
Flag link:
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Alzheimer's disease
drug development
Roche
Merck
Eli Lilly
Biogen
Flag link:
Where are all the new diabetes drugs?
Where are all the new diabetes drugs?
Stat
diabetes
innovation
drug development
Flag link:
5 hurdles facing biosimilar developers
5 hurdles facing biosimilar developers
BioPharma Dive
biosimilars
drug development
drug pricing
legal issues
reimbursement
drug manufacturing
Flag link:
Lexicon developing type 1 diabetes treatment with Sanofi
Lexicon developing type 1 diabetes treatment with Sanofi
Medical Marketing and Media
Lexicon Pharmaceuticals
Sanofi
drug development
type 1 diabetes
Flag link:
No new antidepressants in sight despite growing need, experts warn
No new antidepressants in sight despite growing need, experts warn
Yahoo/Reuters
antidepressants
drug development
Flag link:
4 Signs Glaxo's Turnaround Is Taking Hold
4 Signs Glaxo's Turnaround Is Taking Hold
Motley Fool
GSK
drug development
vaccines
restructuring
Flag link:
Study: Drug development is no faster now than 20 years ago
Study: Drug development is no faster now than 20 years ago
Stat
drug development
R&D
Flag link:
Shire deals RNA platform to Cambridge's RaNa for equity stake
Shire deals RNA platform to Cambridge's RaNa for equity stake
Bizjournals.com
Shire
RNA
RaNA
drug development
Flag link:
Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China
Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China
Yahoo
Sanofi
JHL Biotech
China
biologics
drug development
Flag link:
Hot on the heels of a clinical hold, Arrowhead torches its clinical pipeline, slashes staff
Hot on the heels of a clinical hold, Arrowhead torches its clinical pipeline, slashes staff
Endpoints
Arrowhead Research
R&D
drug development
layoffs
ARC-520
ARC-521
ARC-AAT
Flag link:
AbbVie Ends Halozyme Development Deal
AbbVie Ends Halozyme Development Deal
Investopedia
AbbVie
Halozyme
tnf-alpha
drug development
drug delivery
Flag link:
The development landscape for Non-Alcoholic Steatohepatitis (NASH)
The development landscape for Non-Alcoholic Steatohepatitis (NASH)
BioPharma Dive
NASH
drug development
Covance
CROs
Flag link:
Inovio shares slide after FDA hits it with a hold on lead PhIII HPV program
Inovio shares slide after FDA hits it with a hold on lead PhIII HPV program
Endpoints
Inovio
FDA
HPV
drug development
R&D
Flag link:
Novartis links up with Cerulean in NDC deal
Novartis links up with Cerulean in NDC deal
BioPharma Dive
Novartis
Cerulean
NDCs
drug development
R&D
Flag link:
Celgene Skips the Placebo, Fails Drug Development 101
Celgene Skips the Placebo, Fails Drug Development 101
TheStreet.com
Celgene
drug development
clinical trials
placebo
GED-0301
Crohn's Disease
Flag link:
Exploring Company Contributions To The Origination Of New Medicines
Exploring Company Contributions To The Origination Of New Medicines
Forbes
FDA
drug development
R&D
Flag link:
Novo Nordisk eyes drug development program
Novo Nordisk eyes drug development program
Mass Device
Novo Nordisk
diabetes
drug development
Flag link:
Alnylam CEO: Four Things To Learn From Medicine Development
Alnylam CEO: Four Things To Learn From Medicine Development
Forbes
Alnylam
Pharma CEOs
drug development
Flag link:

Pages